These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 3792641)

  • 1. Prospects for the refinement and reduction of animal usage in the potency testing of Cl. chauvoei vaccines.
    Tilleray JH; Knight PA
    Dev Biol Stand; 1986; 64():111-8. PubMed ID: 3792641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Some observations on the quality control testing of Clostridium chauvoei vaccines.
    Chandler HM
    Dev Biol Stand; 1976; 32():137-41. PubMed ID: 1001827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Veterinary vaccines: In-VITRO--International Veterinary Industry Test Replacement Organisation.
    Redhead K; Lucken R; van de Moer A; Houghton S; Simpson B; Cameron A; Monkton P; Hennesy K; Ellis C
    Dev Biol Stand; 1999; 101():261-6. PubMed ID: 10566800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective cellular antigen of Clostridium chauvoei.
    Stevenson JR; Stonger KA
    Am J Vet Res; 1980 Apr; 41(4):650-3. PubMed ID: 7406286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The preparation of immunogenic cell walls from a highly protective strain of Clostridium chauvoei.
    Chandler HM; Hamilton RC
    J Gen Microbiol; 1975 May; 88(1):27-35. PubMed ID: 1151336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The protective antigen of a highly immunogenic strain of clostridium chauvoei including an evaluation of its flagella as a protective antigen.
    Chandler HM; Gulasekharam J
    J Gen Microbiol; 1974 Sep; 84(1):128-34. PubMed ID: 4436640
    [No Abstract]   [Full Text] [Related]  

  • 7. Development of a cell culture assay for the quantitative determination of vaccination-induced antibodies in rabbit sera against Clostridium perfringens epsilon toxin and Clostridium novyi alpha toxin.
    Borrmann E; Schulze F; Cussler K; Hänel I; Diller R
    Vet Microbiol; 2006 Apr; 114(1-2):41-50. PubMed ID: 16361070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Some problems concerning the assay of Clostridium chauvoei vaccine in laboratory animals.
    Knight PA; Kent J
    Dev Biol Stand; 1976; 32():143-50. PubMed ID: 1001828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The development of an enzyme-linked immunosorbent assay for measuring the potency of vaccines containing Clostridium chauvoei antigens.
    Crichton R; Solomon J; Barton AM
    Biologicals; 1990 Jan; 18(1):49-54. PubMed ID: 2317354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Demonstration of protective antigen carried by flagella of Clostridium chauvoei.
    Tamura Y; Minamoto N; Tanaka S
    Microbiol Immunol; 1984; 28(12):1325-32. PubMed ID: 6533441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Collaborative study for the establishment of a European Pharmacopoeia Biological Reference Preparation for Clostridia antiserum for serological potency testing of veterinary clostridial vaccines.
    Lucken R; Daas A; Behr-Gross ME
    Dev Biol (Basel); 2002; 111():171-80. PubMed ID: 12678238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A serological potency assay for Clostridium chauvoei.
    Hauer PJ; Whitaker MS; Henry LA
    Dev Biol Stand; 1996; 86():331. PubMed ID: 8785971
    [No Abstract]   [Full Text] [Related]  

  • 13. Potency testing of Cl. sordellii bacterin-toxoids by means of a mouse protection test.
    Haas HF
    Dev Biol Stand; 1976; 32():167-72. PubMed ID: 1001830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of a multicomponent standard for clostridial vaccines.
    Gray AK
    Dev Biol Stand; 1976; 32():245-50. PubMed ID: 187507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Progress in the replacement of animal experiments in the quality control of clostridial vaccines].
    Cussler K; Borrmann E; Werner E
    Dtsch Tierarztl Wochenschr; 2002 Apr; 109(4):172-7. PubMed ID: 11998369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of monoclonal antibodies suitable for use in antigen quantification potency tests for clostridial veterinary vaccines.
    Hauer PJ; Clough NE
    Dev Biol Stand; 1999; 101():85-94. PubMed ID: 10566780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diversity in molecular mass of the common EDTA-soluble antigens of Clostridium chauvoei and Clostridium septicum.
    Hamaoka T; Terakado N; Nakamura S
    Microbiol Immunol; 1994; 38(2):149-52. PubMed ID: 7518890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunization of guinea-pigs and cattle with a reduced dose Clostridium chauvoei vaccine produced in a semi-synthetic medium.
    Cameron CM; Botha WJ; Schoeman JH
    Onderstepoort J Vet Res; 1986 Mar; 53(1):51-3. PubMed ID: 3960492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Similarity in the EDTA-soluble antigens of Clostridium chauvoei and C. septicum.
    Hamaoka T; Mori Y; Terakado N; Nakamura S
    J Gen Microbiol; 1993 Mar; 139(3):617-22. PubMed ID: 8473867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Collaborative study for the establishment of erysipelas ELISA coating antigen. European Biological Reference Preparation batch no. 1.
    Cussler K; Rosskopf-Streicher U; Volkers P; Milne C
    Pharmeuropa Spec Issue Biol; 2001 Aug; 2001(1):75-88. PubMed ID: 11705102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.